Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Status Completed

Clinical Trial Summary

This study proposes to use functional magnetic resonance imaging (FMRI) to observe brain activity and behavior associated with decision-making about rewards (DD task), working memory and working memory cognitive persistence (WM task), and craving (CR task) in 72 opiate dependent participants initiating buprenorphine. While stably using opiates (initial study appointment) and again during withdrawal (approximately 3 days later), participants will receive an FMRI scan with behavioral challenges; immediately after the second FMRI, they will receive their first dose of buprenorphine. Buprenorphine treatment will continue for twelve weeks, followed by a four week taper. Urine toxicological analysis will be performed prior to the first scanning session, weekly for two weeks and biweekly thereafter. Participation for all individuals will last 4 months. Assessments will occur at baseline, and weeks 1, 2, 4, 8, and 12. Buprenorphine induction will begin at the completion of the second scan; follow-up medical visits will align with study assessments on weeks 1, 2, 4, 8 and 12. All participants will receive 16 weeks of buprenorphine (the final 4 of these 16 weeks will include a taper).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02696096
Study type	Interventional
Source	Butler Hospital
Contact
Status	Completed
Phase	Phase 3
Start date	August 2016
Completion date	February 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04336293` - sTMS for Substance Use-disordered Veterans	N/A
Completed	`NCT01188421` - Medications Development for Drug Abuse Disorders	Phase 1/Phase 2
Completed	`NCT00499746` - The Discriminative Effects of Tramadol in Humans	Phase 1/Phase 2
Not yet recruiting	`NCT05611749` - Duloxetine Impact on Postoperative Pain Control and Outcomes	Phase 2
Recruiting	`NCT04325659` - An Innovative Intervention for OUD Treatment	Phase 2/Phase 3
Completed	`NCT03685162` - Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Treatment
Recruiting	`NCT04239235` - Integrating Support Persons Into Recovery	N/A
Not yet recruiting	`NCT03394911` - Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction	Phase 3
Not yet recruiting	`NCT02282072` - PINS Stimulator System for Deep Brain Stimulation of the Nucleus Accumbens to Treat Severe Opioid Addiction	Phase 0
Not yet recruiting	`NCT01008072` - Ultra-rapid Opiate Detoxification Using Deep Sedation and Prior Oral Buprenorphine Preparation.	N/A
Recruiting	`NCT05299515` - Peer Activate: Trial of Peer-Delivered Behavioral Activation for Methadone Adherence	N/A
Recruiting	`NCT04309565` - Transitions Clinic Network: Post Incarceration Addiction Treatment, Healthcare, and Social Support	N/A
Completed	`NCT01873989` - Testosterone Replacement for Male Opioid Agonist Maintained Patients	Phase 1/Phase 2
Completed	`NCT01590251` - Yoga for Pain and Opioid Dependence	Phase 1/Phase 2
Active, not recruiting	`NCT02866266` - ER/LA Opioid Surveillance for Emergency Department Visits and Hospitalizations for Overdose and Poisoning	N/A
Enrolling by invitation	`NCT02871232` - Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers	N/A